Current ANZIC-RC Advisory Board Members
The ANZIC-RC is administered by an Advisory Board. The current ANZIC-RC Advisory Board Members are:
|Professor (DJ) Jamie Cooper AO BMBS MD FRACP FCICM FAHMS|
Monash University Director of the ANZIC-RC
Professor Cooper is Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC); Director of the NHMRC Centre of Research Excellence for Patient Blood Management in Critical Illness and Trauma (Blood-CRE); Head of the Acute and Critical Care Division in the School of Public Health and Preventive Medicine, all at Monash University; and Senior Specialist in Intensive Care, Head of ICU Research and Deputy Director of the Department of Intensive Care at The Alfred Hospital, Melbourne. In 2017, he was awarded an Officer of the Order of Australia (AO) for distinguished service to intensive care medicine in the field of traumatic brain injury as a clinician, and to medical education as an academic, researcher and author. He is a National Health and Medical Research Council (NHMRC) Practitioner Fellow, full Professor of Intensive Care Medicine at Monash University and Hon. Professorial Fellow in the Critical Care and Trauma Division at The George Institute for Global Health, University of Sydney. He has published more than 290 journal papers including 18 in New England Journal of Medicine (NEJM), Lancet, Journal of the American Medical Association (JAMA) and Annals of Internal Medicine. He has been a Principal or Co-investigator on peer reviewed research grants exceeding $64 million including 24 NHMRC grants. Research foci include randomised clinical trials in traumatic brain injury, sepsis, acute lung injury, resuscitation fluids, and blood transfusion.
|Professor Rinaldo Bellomo AO MBBS MD PhD FRACP FCICM FAHMS|
Monash University Co-Director of the ANZIC-RC, and College of Intensive Care Medicine (CICM) Representative
Rinaldo Bellomo is a Professor of Intensive Care Medicine, University of Melbourne, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Monash University, Melbourne Australia; Honorary Professorial Fellow, Faculty of Medicine, The University of Sydney, Sydney, Australia; Honorary Professorial Fellow, The George Institute, Sydney, Australia; Honorary Fellow, Florey Institute of Physiology, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Nanjing University, Nanjing, China; and Visiting Professor, Università Vita-Salute San Raffaele, Milan, Italy. In 2018, he was awarded an Officer of the Order of Australia for distinguished service to intensive care medicine as a biomedical scientist and researcher, through infrastructure and systems development to manage the critically ill, and as an author.
Professor Bellomo is the Director of Intensive Care Research and Staff Specialist in Intensive Care at Austin Health. He is Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) - a methods centre (established with a National Health and Medical Research Council (NHMRC) Enabling Grant) for investigator-initiated clinical research that supports >15 staff, >10 PhD candidates, and research programs in traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics. He is a NHMRC Practitioner Fellow and was Foundation Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG).
Each year for the past five years (2014-2018), Professor Bellomo has been named one of the world's most influential scientific minds of our time. Clarivate Analytics publishes "The world's most influential scientific minds" based on its analysis of data over the previous 11 years using Web of Science and InCites platforms to determine which researchers have produced work that is most frequently acknowledged by peers. Prof Bellomo is one of the researchers identified as "influencing the future direction of their field, and of the world", "on the cutting edge of their field" and "publishing work that their peers recognize as vital to the advancement of their science". He is also the recipient of a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award.
In 2015, Professor Bellomo became the first ANZ biomedical researcher to have more than 1,000 papers in Scopus. He has also written more than 152 book chapters and edited 13 books in the field of intensive care medicine. As at November, in Scopus he had >1,360 papers, an h index of 112, and total lifetime citations of >68,000; and a yearly citation rate over the past 5 years of >2,500. He is the Editor-in-Chief of the journal Critical Care and Resuscitation.
Professor Bellomo has been Chief Investigator in many successful grant applications. Over the past 10 years, he has been heavily involved in the design, execution, supervision and publication of several large randomised controlled trials published in The Lancet and the New England Journal of Medicine (NEJM) for >20,000 intensive care unit (ICU) patients randomised.
|Professor Alistair Nichol BA(Hons) MB BCh BAO(Hons) DipMan FCARCSI FJFICMI FCICM PhD Co-Deputy Director and Professor of Intensive Care Medicine, ANZIC-RC
Alistair is a Professor of Intensive Care Medicine in the School of Public Health and Preventive Medicine, Monash University, and an Intensive Care Clinician at The Alfred Hospital, Melbourne. Following completion of a PhD at University College Dublin, Alistair commenced with the ANZIC-RC in 2007 and has worked on a number of its large multi-centre randomised controlled trials. He was a Chief Investigator on the POLAR-RCT, PHARLAP and EPO-TBI trials. His areas of interest include traumatic brain injury (TBI), acute respiratory distress syndrome (ARDS) and mechanical ventilation. Alistair has completed over 10 years of training in Anaesthesia, Intensive Care and Pain Medicine. He was awarded the Fellowship of the College of Anaesthetists, Royal College of Surgeons Ireland (FCARCSI) in 2002, and the Fellowship of the College of Intensive Care Medicine Australia and New Zealand (FCICM) in 2010. Alistair was also awarded a Victorian Neurotrauma Initiative (VNI) Early Career Practitioner Fellowship.
|Professor Andrew Udy BHB MB ChB PGCert(AME) PhD FCICM |
Co-Deputy Director, ANZIC-RC
Prof Andrew Udy is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University, and a full-time intensive care clinician and researcher at The Alfred ICU, Melbourne. He completed his undergraduate medical education at the University of Auckland, followed by ICU training in New Zealand, the United Kingdom and Australia. After award of Fellowship, Andrew worked as a consultant for many years in Queensland, while also completing a PhD in antibiotic pharmacokinetics. His major academic interests include optimised drug prescribing in the critically ill, haemodynamic management in severe sepsis, acute kidney injury and renal replacement therapy, management of subarachnoid haemorrhage, and critical care nutrition. Andrew is involved in critical care research internationally as the Victorian representative on the ANZICS Clinical Trials Group (CTG) Committee. He is also a keen educator; instructing on BASIC, ALS, ECMO and EMST courses, and is Deputy Chair of the Victorian Regional Committee (VRC), College of Intensive Care Medicine.
|Professor Carol Hodgson PhD FACP|
Co-Deputy Director, ANZIC-RC
Professor Carol Hodgson is Head of the Division of Clinical Trials and Cohort Studies in the School of Public Health and Preventive Medicine, and Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia. She has held NHMRC funding throughout her career, as PhD scholarship, Early Career Fellowship and currently with an Investigator Grant (2020-2024). She is a Specialist Physiotherapist in Intensive Care at The Alfred Hospital, Melbourne, Australia. She sits on the Executive and Scientific Committee of the International ECMO Network (ECMONet), the Guidelines Leadership Group for National COVID-19 Clinical Evidence Taskforce and is a Council Member of the International Forum of Acute Care Trialists (InFACT). She leads international multicentre trials for the Australian and New Zealand Intensive Care Society Clinical Trials Group. She has over $20M in grant funding and over 190 publications, with expertise in long-term functional recovery after critical illness. She has contributed to international guidelines for the management of patients with acute respiratory distress syndrome, sepsis and COVID-19, including recommendations for the use of mechanical ventilation, high-flow nasal therapy, oxygen, extracorporeal membrane oxygenation, and early rehabilitation.
|Professor Sophia Zoungas MBBS(Hons) FRACP PhD|
Head, Monash University School of Public Health and Preventive Medicine
Professor Zoungas is Head of the School of Public Health and Preventive Medicine at Monash University. She is an academic endocrinologist with a national and international reputation as a clinical researcher in the fields of diabetes and vascular risk. In this capacity she directs and supports projects on diabetes, cardiovascular health, kidney health and health care delivery, as well as advise on clinical epidemiological methods and trial design/conduct/reporting. Prof Zoungas is President of the Australian Diabetes Society, a Director on the Board of Diabetes Australia, and Clinical Director of the National Association of Diabetes Centres.
|Professor Sandra L Peake BMBS BSc(Hons) FCICM PhD|
Chair, Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG)
Prof Peake is a Senior Intensive Care Clinician in the Department of Intensive Care Medicine at The Queen Elizabeth Hospital, Adelaide and Professor in the School of Medicine at the University of Adelaide. She is Chair of the Intensive Care Foundation Scientific Committee, Chair of the Research Committee for the Acute Care Medicine Discipline at the University of Adelaide and Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). She has been an examiner for the College of Intensive Care Medicine for the past 8 years. In 2000, she completed her PhD in Medicine at the University of Adelaide in the field of sepsis. Her thesis examined the role of combination anti-cytokine immunotherapy in an animal model of septic shock. Her main research interest now is large-scale, randomised clinical trials in critical care. She was Chair of the Management Committee for the NHMRC-funded, CTG-endorsed Australasian Resuscitation In Sepsis Evaluation (ARISE) multi-centre trial of early resuscitation in sepsis, and was also a member of the Management Committee for the NHMRC-funded, CTG-endorsed multi-centre clinical trial of Early Parenteral Nutrition.
|Clinical Associate Professor Craig French|
Immediate Past Chair, Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG)
A/Prof Craig French is a specialist Intensive Care Physician and Anaesthetist. He is the Director of Intensive Care at Western Health, Melbourne, Australia; a Clinical Associate Professor of the University of Melbourne; and the Immediate Past Chair of the ANZICS Clinical Trials Group. His primary interests are multicentre clinical research, clinical ethics, and guideline development.
|Professor David Pilcher MBBS MRCP FCICM FRACP|
Representative of the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (ANZICS-CORE)
Professor Dave Pilcher has worked as an Intensive Care Specialist at The Alfred Hospital in Melbourne since 2006. He trained in respiratory and general medicine in the United Kingdom before coming to Australia to complete his Intensive Care fellowship in 2002. Professor Pilcher is Director of the ANZICS Adult Patient Database and the representative of the ANZICS-CORE. He holds an Intensive Care Practitioner fellowship with Monash University. His research interests include organ donation, lung transplantation and the epidemiology of intensive care unit outcomes.
|Dr Colin McArthur|
Representative of the New Zealand intensive care research community
Dr Colin McArthur is a Past Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). He is Clinical Director, Department of Critical Care Medicine, Auckland City Hospital; Medical Advisor - Quality & Safety, Auckland District Health Board; and Honorary Clinical Lecturer, Department of Surgery, University of Auckland. He trained in medicine in Auckland and is a Fellow of the College of Intensive Care Medicine (FCICM) and a Fellow of the Australian and New Zealand College of Anaesthetists (FANZCA). He has been an investigator in >30 investigator-initiated studies (and also >15 commercial studies) and an author of >60 publications, mostly multi-centre clinical intensive care research. Since 2001, he has been on the management and/or writing committee of 11 NHMRC or HRCNZ-funded studies, six of which have been completed and published in the New England Journal of Medicine and five are on-going. He was an investigator on several ANZIC-RC studies including the EPO-TBI, POLAR, SPICE, ARISE, INFINITE , and STATINS studies. His interests include research methodology and ethics, traumatic brain injury, sepsis, nutrition, and severe influenza.
|Dr Shay McGuinness|
Representative of the New Zealand intensive care research community
Dr Shay McGuinness is Director of Research at the Cardiothoracic and Vascular Intensive Care Unit (CVICU), Auckland City Hospital, New Zealand, and Clinical Director of the Air Ambulance Service, Auckland District Health Board. Dr McGuinness is the New Zealand representative on the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) Executive and is the Chair of the ANZICS-CTG Capacity Working Group Sub-committee. Dr McGuinness trained at medicine and surgery in Sheffield, United Kingdom. He has published more than 25 journal papers including articles in New England Journal of Medicine (NEJM) and Journal of the American Medical Association (JAMA). He has been a Principal or Co-investigator on peer reviewed research grants exceeding (NZ)$2.9 million including 5 NZHRC grants. His research interests include randomised clinical trials in non-invasive ventilation and renal failure. Dr McGuinness is a member of the Management Committee of the ANZIC-RC's Supplemental PN trial, and was a member on the completed PHARLAP-RCT trial.
Past Advisory Board Members
The ANZIC-RC would like to thank all of its past Advisory Board Members for their valuable contribution. Past ANZIC-RC Advisory Board Members include:
- Professor John Myburgh
- Dr Peter Hicks
- Professor Simon Finfer
- Professor Bala Venkatesh
- Dr Tim Sutton
- Associate Professor Graeme Hart
- Associate Professor Michael O'Leary
- Associate Professor Robert Boots
- Associate Professor Mary White
- Associate Professor Dianne Stephens
- Associate Professor Andrew Turner
- Dr Marc Ziegenfuss
- Professor Steve Webb
- Professor Erica Wood
- Mr Peter Gallagher
- Professor John McNeil
Terms of Reference
The ANZIC-RC is governed by its Terms of Reference (PDF 1.5 MB).